Bridge City Capital LLC boosted its stake in shares of Exponent, Inc. (NASDAQ:EXPO - Free Report) by 7.5% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 53,286 shares of the business services provider's stock after buying an additional 3,739 shares during the quarter. Exponent makes up 1.3% of Bridge City Capital LLC's portfolio, making the stock its 27th largest position. Bridge City Capital LLC owned 0.10% of Exponent worth $4,748,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other large investors also recently added to or reduced their stakes in EXPO. State Street Corp increased its position in shares of Exponent by 0.7% during the third quarter. State Street Corp now owns 1,840,313 shares of the business services provider's stock worth $212,151,000 after acquiring an additional 13,644 shares during the period. Geode Capital Management LLC increased its holdings in Exponent by 4.8% during the 3rd quarter. Geode Capital Management LLC now owns 1,505,652 shares of the business services provider's stock worth $173,597,000 after purchasing an additional 69,099 shares during the period. JPMorgan Chase & Co. raised its position in Exponent by 63.6% during the 3rd quarter. JPMorgan Chase & Co. now owns 630,644 shares of the business services provider's stock valued at $72,701,000 after purchasing an additional 245,086 shares in the last quarter. Raymond James Financial Inc. bought a new stake in Exponent during the 4th quarter valued at $55,131,000. Finally, Charles Schwab Investment Management Inc. lifted its holdings in shares of Exponent by 1.5% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 525,378 shares of the business services provider's stock worth $46,811,000 after buying an additional 7,766 shares during the period. 92.37% of the stock is owned by hedge funds and other institutional investors.
Exponent Trading Up 2.0 %
Shares of Exponent stock traded up $1.63 during trading on Thursday, hitting $82.04. 263,223 shares of the stock traded hands, compared to its average volume of 216,684. The stock's fifty day simple moving average is $86.99 and its 200 day simple moving average is $95.90. The firm has a market cap of $4.17 billion, a P/E ratio of 38.70 and a beta of 0.77. Exponent, Inc. has a 52-week low of $77.30 and a 52-week high of $115.75.
Exponent (NASDAQ:EXPO - Get Free Report) last issued its earnings results on Thursday, February 6th. The business services provider reported $0.46 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.40 by $0.06. Exponent had a net margin of 19.52% and a return on equity of 27.27%. During the same quarter in the previous year, the business posted $0.41 EPS. As a group, equities analysts expect that Exponent, Inc. will post 1.98 EPS for the current year.
Insider Activity at Exponent
In other Exponent news, VP Richard Reiss sold 1,736 shares of the company's stock in a transaction on Wednesday, February 26th. The stock was sold at an average price of $85.93, for a total transaction of $149,174.48. Following the completion of the sale, the vice president now owns 1,800 shares in the company, valued at $154,674. This represents a 49.10 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 2.10% of the stock is currently owned by corporate insiders.
About Exponent
(
Free Report)
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Further Reading
Before you consider Exponent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.
While Exponent currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
